Global Rapid Antigen Detection Tests Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

The "Rapid Antigen Detection Tests - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Rapid Antigen Detection Tests estimated at US$199.9 Million in the year 2020, is projected to reach a revised size of US$355.9 Million by 2027, growing at a CAGR of 8.6% over the period 2020-2027.

The U.S. Market is Estimated at $54 Million, While China is Forecast to Grow at 13% CAGR

The Rapid Antigen Detection Tests market in the U.S. is estimated at US$54 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$82.1 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Select Competitors (Total 34 Featured):

• Abbott Laboratories
• Acumen Research Laboratories
• Beijing Tigsun Diagnostics Co. Ltd.
• Biolidics
• Biomaxima
• BioMedomics
• CTK Biotech
• Getein Biotech
• LabCorp
• ThermoFisher

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of COVID-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 34

For more information about this report visit https://www.researchandmarkets.com/r/mvy1xy

View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005434/en/